10X Capital Management, LLC, 10% Owner at GALECTIN THERAPEUTICS INC (GALT), sold 10,000 shares at $2.10 ($21K) on 2022-01-11, disclosed to the SEC on 2022-01-13.
Scheduled sale ($21k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GALT | SELL | 2025-10-24 | $247K | — | Filing → |
| GALT | SELL | 2021-11-04 | $32K | — | Filing → |
| GALT | SELL | 2020-01-21 | $30K | — | Filing → |